Novartis loses initial bid to block MSN's generic EntrestoMSN's version of the heart failure drug Entresto would be the first U.S. generic of the drug. Alembic receives FDA OK for generic ArranonNelarabine is indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and lymphoma in certain patients. Ahold Delhaize USA names Moira O’Toole VP of pharmacy services With more than 24 years of experience with the companies of Ahold Delhaize USA, O’Toole most recently served as director of patient health services. Con-Cret earns NSF’S Certified for Sport certification The brand said it engages in the highest level of third-party certification and quality assurance. Sandoz receives FDA approval for Eyelea biosimilar Enzeevu is approved to treat neovascular age-related macular degeneration. FDA approves first nasal spray for anaphylaxis ARS Pharmaceutical's Neffy is used for the emergency treatment of life-threatening allergic reactions in adult and pediatric patients. FDA gives Lupin nod for generic Pred Forte, tentative OK for generic Descovy The company received approval for generic Pred Forte and generic Descovy. Mallinckrodt to sell Therakos business to CVC for $925M Therakos is a fully integrated extracorporeal photopheresis delivery system for autologous immunomodulatory therapy. ANI Pharmaceuticals announces proposed convertible senior notes offering ANI also expects to grant the initial purchasers of the notes an option to purchase. Upsher-Smith intros Torpenz Torpenz is an oral mTOR inhibitor used in patients with tuberous sclerosis complex. First Previous 23 24 25 26 27 Next Last
